India’s Drug Regulator Wants the World to Rethink Its Assumptions
From stricter standards to cutting-edge therapies, DCGI Dr. Rajeev Singh Raghuvanshi outlines how India is repositioning itself as a global pharmaceutical force.
Building a Resilient Oxygen Infrastructure for India’s Healthcare Future
We see huge untapped potential for Rainbow Hospitals in North and East: Dr Ramesh Kancharla
Fast-Acting Therapy: Indian Pharma Broadens Focus Beyond Generics
